SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Bank of New York Mellon Corp – ‘10-Q’ for 6/30/16 – ‘EX-10.2’

On:  Monday, 8/8/16, at 4:35pm ET   ·   For:  6/30/16   ·   Accession #:  1390777-16-246   ·   File #:  1-35651

Previous ‘10-Q’:  ‘10-Q’ on 5/10/16 for 3/31/16   ·   Next:  ‘10-Q’ on 11/8/16 for 9/30/16   ·   Latest:  ‘10-Q’ on 11/3/23 for 9/30/23   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 8/08/16  Bank of New York Mellon Corp      10-Q        6/30/16  124:34M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   2.73M 
 2: EX-10.1     Form of Amended and Restated Director               HTML     78K 
                Indemnification Agreement                                        
 3: EX-10.2     Form of Amended and Restated Executive Officer      HTML     80K 
                Indemnification Agreement                                        
 4: EX-10.3     The Bank of New York Mellon Corporation Form of     HTML     75K 
                Restricted Stock Unit Agreement                                  
 5: EX-10.4     The Bank of New York Mellon Corporation Form of     HTML     77K 
                Performance Share Unit Agreement                                 
 6: EX-12.1     Computation of Ratio of Earnings to Combined Fixed  HTML     62K 
                Charges and Preferred Stock                                      
 7: EX-31.1     Section 302 CEO Certification                       HTML     42K 
 8: EX-31.2     Section 302 CFO Certification                       HTML     42K 
 9: EX-32.1     Section 906 CEO Certification                       HTML     37K 
10: EX-32.2     Section 906 CFO Certification                       HTML     37K 
17: R1          Document and Entity Information                     HTML     55K 
18: R2          Consolidated Income Statement (Unaudited)           HTML    209K 
19: R3          Consolidated Income Statement (Unaudited)           HTML     38K 
                (Parenthetical)                                                  
20: R4          Consolidated Comprehensive Income Statement         HTML     87K 
                (Unaudited)                                                      
21: R5          Consolidated Comprehensive Income Statement         HTML     39K 
                (Unaudited) (Parenthetical)                                      
22: R6          Consolidated Balance Sheet (Unaudited)              HTML    175K 
23: R7          Consolidated Balance Sheet (Unaudited)              HTML     63K 
                (Parenthetical)                                                  
24: R8          Consolidated Statement of Cash Flows (Unaudited)    HTML    181K 
25: R9          Consolidated Statement of Changes in Equity         HTML     83K 
                (Unaudited)                                                      
26: R10         Consolidated Statement of Changes in Equity         HTML     41K 
                (Unaudited) (Parenthetical)                                      
27: R11         Basis of Presentation                               HTML     41K 
28: R12         Acquisitions and Dispositions                       HTML     43K 
29: R13         Securities                                          HTML    557K 
30: R14         Loans and asset quality                             HTML    610K 
31: R15         Goodwill and Intangible Assets                      HTML    175K 
32: R16         Other Assets                                        HTML     83K 
33: R17         Net Interest Revenue                                HTML     98K 
34: R18         Employee Benefit Plans                              HTML    102K 
35: R19         Restructuring Charges                               HTML     41K 
36: R20         Income Taxes                                        HTML     43K 
37: R21         Securitizations and Variable Interest Entities      HTML     97K 
38: R22         Preferred Stock                                     HTML     84K 
39: R23         Other Comprehensive Income (Loss)                   HTML    181K 
40: R24         Fair Value Measurement                              HTML    838K 
41: R25         Fair Value Option                                   HTML     77K 
42: R26         Derivative Instruments                              HTML    528K 
43: R27         Commitments and Contingent Liabilities              HTML    127K 
44: R28         Lines of Businesses                                 HTML    231K 
45: R29         Supplemental information to the Consolidated        HTML     51K 
                Statement of Cash Flows                                          
46: R30         Basis of Presentation (Policies)                    HTML     53K 
47: R31         Securities (Tables)                                 HTML    554K 
48: R32         Loans and asset quality (Tables)                    HTML    605K 
49: R33         Goodwill and Intangible Assets (Tables)             HTML    174K 
50: R34         Other Assets (Tables)                               HTML     77K 
51: R35         Net Interest Revenue (Tables)                       HTML     98K 
52: R36         Employee Benefit Plans (Tables)                     HTML    101K 
53: R37         Securitizations and Variable Interest Entities      HTML    102K 
                (Tables)                                                         
54: R38         Preferred Stock (Tables)                            HTML     66K 
55: R39         Other Comprehensive Income (Loss) (Tables)          HTML    178K 
56: R40         Fair Value Measurement (Tables)                     HTML    850K 
57: R41         Fair Value Option (Tables)                          HTML     76K 
58: R42         Derivative Instruments (Tables)                     HTML    514K 
59: R43         Commitments and Contingent Liabilities (Tables)     HTML     85K 
60: R44         Lines of Businesses (Tables)                        HTML    208K 
61: R45         Supplemental information to the Consolidated        HTML     49K 
                Statement of Cash Flows (Tables)                                 
62: R46         Acquisitions and Dispositions- Additional           HTML     75K 
                Information (Detail)                                             
63: R47         Securities - Amortized Cost, Gross Unrealized       HTML    151K 
                Gains and Losses and Fair Value of Securities                    
                (Detail)                                                         
64: R48         Securities - Net Securities Gains (Losses)          HTML     44K 
                (Detail)                                                         
65: R49         Securities - Aggregate Fair Value of Investments    HTML    171K 
                with Continuous Unrealized Loss Position (Detail)                
66: R50         Securities - Maturity Distribution by Carrying      HTML    157K 
                Amount and Yield (on Tax Equivalent Basis) of                    
                Investment Securities Portfolio (Detail)                         
67: R51         Securities - Projected Weighted-Average Default     HTML     47K 
                Rates and Loss Severities (Detail)                               
68: R52         Securities - Pre-Tax Net Securities Gains (Losses)  HTML     51K 
                by Type (Detail)                                                 
69: R53         Securities - Debt Securities Credit Losses Roll     HTML     47K 
                Forward Recorded in Earnings (Detail)                            
70: R54         Securities - Pledged assets (Details)               HTML     60K 
71: R55         Loans and asset quality - Details of Loan           HTML     91K 
                Distribution and Industry Concentrations of Credit               
                Risk (Detail)                                                    
72: R56         Loans and asset quality - Allowance for Credit      HTML    219K 
                Losses Activity (Detail)                                         
73: R57         Loans and asset quality - Nonperforming Assets      HTML     54K 
                (Detail)                                                         
74: R58         Loans and asset quality - Lost Interest (Detail)    HTML     40K 
75: R59         Loans and asset quality - Information about         HTML    105K 
                Impaired Loans (Detail)                                          
76: R60         Loans and asset quality - Information about Past    HTML     75K 
                Due Loans (Detail)                                               
77: R61         Loans and asset quality- Troubled Debt              HTML     50K 
                Restructurings (Detail)                                          
78: R62         Loans and asset quality - Credit Quality            HTML     65K 
                Indicators - Wealth Management Loans and Mortgages               
                - Credit Risk Profile by Internally Assigned Grade               
                (Detail)                                                         
79: R63         Loans and asset quality - Additional Information    HTML    118K 
                (Detail)                                                         
80: R64         Goodwill and Intangible Assets - Goodwill by        HTML     59K 
                Business Segment (Detail)                                        
81: R65         Goodwill and Intangible Assets - Intangible Assets  HTML     57K 
                by Business Segment (Detail)                                     
82: R66         Goodwill and Intangible Assets - Intangible Assets  HTML     75K 
                by Type (Detail)                                                 
83: R67         Goodwill and Intangible Assets - Estimated Annual   HTML     47K 
                Amortization Expense (Detail)                                    
84: R68         Goodwill and Intangible Assets goodwill and         HTML     42K 
                intangible assets - additional information                       
                (Details)                                                        
85: R69         Other Assets (Detail)                               HTML     68K 
86: R70         Other Assets - Seed Capital and Private Equity      HTML     56K 
                Investments Valued Using Net Asset Value (Detail)                
87: R71         Other Assets - Additional Information (Details)     HTML     58K 
88: R72         Net Interest Revenue (Detail)                       HTML     84K 
89: R73         Employee Benefit Plans - Net Periodic Benefit       HTML     64K 
                (Credit) Cost (Details)                                          
90: R74         Restructuring Charges - Additional Information      HTML     51K 
                (Detail)                                                         
91: R75         Income Taxes (Detail)                               HTML     53K 
92: R76         Securitizations and Variable Interest Entities -    HTML     76K 
                Incremental Assets and Liabilities of Variable                   
                Interest Entities Included in Consolidated                       
                Financial Statements (Detail)                                    
93: R77         Securitizations and Variable Interest Entities -    HTML     46K 
                Non-consolidated Variable Interest Entities                      
                (Detail)                                                         
94: R78         Preferred Stock - Additional Information (Detail)   HTML     82K 
95: R79         Preferred Stock - Stock Summary (Details)           HTML     70K 
96: R80         Other Comprehensive Income (Loss) - Components of   HTML    112K 
                Other Comprehensive Income (Detail)                              
97: R81         Fair Value Measurement - Assets and Liabilities     HTML    385K 
                Measured at Fair Value on Recurring Basis (Detail)               
98: R82         Fair Value Measurement- Details of Certain Items    HTML    222K 
                Measured at Fair Value on Recurring Basis (Detail)               
99: R83         Fair Value Measurement - Significant Unobservable   HTML    114K 
                Inputs (Detail)                                                  
100: R84         Fair Value Measurement - Assets Measured at Fair    HTML     57K  
                Value on Nonrecurring Basis (Detail)                             
101: R85         Fair Value Measurement - Quantitative Information   HTML     54K  
                about Level 3 Fair Value Measurements of Assets                  
                (Detail)                                                         
102: R86         Fair Value Measurement - Carrying Amount and Fair   HTML     87K  
                Value of Financial Instruments (Detail)                          
103: R87         Fair Value Measurement- Summary of Carrying Amount  HTML     47K  
                of Hedged Financial Instruments, Related Notional                
                Amount of Hedge and Estimated Fair Value of                      
                Derivatives (Detail)                                             
104: R88         Fair Value Option - Assets and Liabilities, by      HTML     51K  
                Type, of Consolidated Investment Management Funds                
                Recorded at Fair Value (Detail)                                  
105: R89         Fair Value Option - Changes in Fair Value of the    HTML     45K  
                Loans and Long-Term Debt and the Location of the                 
                Changes (Detail)                                                 
106: R90         Fair Value Option - Additional Information          HTML     45K  
                (Detail)                                                         
107: R91         Derivative Instruments - Additional Information     HTML     81K  
                (Detail)                                                         
108: R92         Derivative Instruments - Ineffectiveness Related    HTML     48K  
                to Derivatives and Hedging Relationships Recorded                
                in Income (Detail)                                               
109: R93         Derivative Instruments - Impact of Derivative       HTML     98K  
                Instruments on Balance Sheet (Detail)                            
110: R94         Derivative Instruments - Impact of Derivative       HTML     83K  
                Instruments on Income Statement (Detail)                         
111: R95         Derivative Instruments - Revenue from Foreign       HTML     45K  
                Exchange and Other Trading (Detail)                              
112: R96         Derivative Instruments - Fair Value of Derivative   HTML     50K  
                Contracts Falling under Early Termination                        
                Provisions in Net Liability Position (Detail)                    
113: R97         Derivative Instruments - Offsetting (Details)       HTML    243K  
114: R98         Derivative Instruments - Secured borrowings         HTML     93K  
                (Details)                                                        
115: R99         Commitments and Contingent Liabilities -            HTML     79K  
                Significant Industry Concentrations Related to                   
                Credit Exposure (Detail)                                         
116: R100        Commitments and Contingent Liabilities - Summary    HTML     51K  
                of Off-Balance Sheet Credit Risks, Net of                        
                Participations (Detail)                                          
117: R101        Commitments and Contingent Liabilities - Standby    HTML     43K  
                Letters of Credits by Investment Grade (Detail)                  
118: R102        Commitments and Contingent Liabilities -            HTML     95K  
                Additional Information (Detail)                                  
119: R103        Lines of Businesses - Additional Information        HTML     36K  
                (Detail)                                                         
120: R104        Lines of Businesses- Contribution of Segments to    HTML    103K  
                Overall Profitability (Detail)                                   
121: R105        Supplemental information to the Consolidated        HTML     55K  
                Statement of Cash Flows- Noncash Investing and                   
                Financing Transactions that are Not Reflected in                 
                Consolidated Statement of Cash Flows (Detail)                    
123: XML         IDEA XML File -- Filing Summary                      XML    228K  
122: EXCEL       IDEA Workbook of Financial Reports                  XLSX    197K  
11: EX-101.INS  XBRL Instance -- bk-20160630                         XML  14.23M 
13: EX-101.CAL  XBRL Calculations -- bk-20160630_cal                 XML    460K 
14: EX-101.DEF  XBRL Definitions -- bk-20160630_def                  XML   1.59M 
15: EX-101.LAB  XBRL Labels -- bk-20160630_lab                       XML   3.30M 
16: EX-101.PRE  XBRL Presentations -- bk-20160630_pre                XML   2.05M 
12: EX-101.SCH  XBRL Schema -- bk-20160630                           XSD    353K 
124: ZIP         XBRL Zipped Folder -- 0001390777-16-000246-xbrl      Zip    740K  


‘EX-10.2’   —   Form of Amended and Restated Executive Officer Indemnification Agreement


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Exhibit  


Exhibit 10.2

FORM OF AMENDED AND RESTATED
EXECUTIVE OFFICER INDEMNIFICATION AGREEMENT
This AMENDED AND RESTATED INDEMNIFICATION AGREEMENT is made this ___ day of [month], [year] (the "Agreement") by and between The Bank of New York Mellon Corporation (the "Company") and [          ] ("Indemnitee").
WHEREAS, the Company and the Indemnitee previously entered into an Indemnification Agreement (the “Prior Agreement”);
WHEREAS, pursuant to the Prior Agreement, the Company and the Indemnitee wish to amend and restate the Prior Agreement to read as set forth herein;
WHEREAS, Indemnitee is an Executive Officer (as hereinafter defined) of the Company and may also be serving or may serve in the future in another Position (as hereinafter defined) at an Affiliated Entity or Unaffiliated Entity (each as hereinafter defined);
WHEREAS, in consideration of the Indemnitee acting in the Position or Positions and assuming the responsibilities attendant to the Position or Positions, the Company desires to provide Indemnitee the rights to indemnification and payment or reimbursement of expenses described below;
NOW, THEREFORE, in consideration of the premises and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and Indemnitee do hereby covenant and agree as follows:
Section 1. Definitions. For purposes of this Agreement:
(a)    “Change of Control” means, and shall be deemed to have occurred if, on or after the date of this Agreement, (i) any “person” (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended), other than (A) a trustee or other fiduciary holding securities under an employee benefit plan of the Company or any of its subsidiaries acting in such capacity, or (B) a corporation owned directly or indirectly by the stockholders of the Company in substantially the same proportions as their ownership of stock of the Company, is or becomes the “beneficial owner” (as defined in Rule 13d-3 under such Act), directly or indirectly, of securities of the Company representing more than 20% of the total voting power represented by the Company’s then outstanding Voting Securities, (ii) during any period of two consecutive years, individuals who at the beginning of such period constitute the board of directors of the Company and any new director whose election by the board of directors of the Company or nomination for election by the Company’s stockholders was approved by a vote of at least two-thirds (2/3) of the directors then still in office who either were directors at the beginning of the period or whose election or nomination for election was previously so approved, cease for any reason to constitute a majority thereof, (iii) the stockholders of the Company approve a merger or consolidation of the Company with any other corporation other than a merger or consolidation that would result in the Voting Securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into Voting Securities of the surviving entity) at least 80% of the total voting power represented by the Voting Securities of the Company or such surviving entity outstanding immediately after such merger or consolidation, (iv) the stockholders of the Company approve a plan of complete liquidation of the Company or an agreement for the sale or disposition by the Company of (in one transaction or a series of related transactions) all or substantially all of its assets, or (vthe Company shall file or have filed against it, and such filing shall not be dismissed, any bankruptcy, insolvency or dissolution proceedings, or a trustee, administrator or creditors committee shall be appointed to manage or supervise the affairs of the Company.


    



(b)    "Executive Officer" shall have the meaning of the term "officer" as such term is defined in Rule 16a-l(f) of the Securities Exchange Act of 1934, as amended.
(c)    "Expenses" shall include all out of pocket fees, costs and expenses, including, without limitation, attorneys' fees, retainers, court costs, transcript costs, fees of experts, witness fees, travel expenses, duplicating costs, printing and binding costs, postage, delivery service fees, and all other disbursements or expenses of the types customarily incurred if Indemnitee is involved in any manner (including, without limitation, as a party or a witness) in any Proceeding (as hereinafter defined) and the fees and costs incurred in seeking to enforce, interpret or construe an indemnification, reimbursement or payment right under this Agreement, the Company’s or any subsidiary’s certificate of incorporation or bylaws, the Company’s Indemnification Policy, any other agreement to which Indemnitee and the Company or any of its subsidiaries are party, any vote of stockholders or directors of the Company or any of its subsidiaries, the Delaware General Corporation Law (the “DGCL”), any other applicable law or any liability insurance policy or in connection with a determination contemplated by Section 5 of this Agreement.
(d)    “FDIC Regulations” means regulations of the Federal Deposit Insurance Corporation (or any successor provisions).
(e)    “Position” means (a) service as a director, officer, partner, trustee, fiduciary, manager or employee of the Company or Company advisory board or of any other corporation, limited liability company, public limited company, partnership, joint venture, trust, employee benefit plan, fund or other enterprise as to which the Company beneficially owns, directly or indirectly, at least a majority of the voting power of equity or membership interests, or in the case of employee benefit plans, is sponsored or maintained by the Company or one of the foregoing (any of the foregoing, an “Affiliated Entity”) or (b) service at the request of the Company at any time this Agreement is in effect as a director, officer, partner, trustee, fiduciary, manager or employee of a corporation, limited liability company, public limited company, partnership, joint venture, trust, employee benefit plan, fund or other enterprise which is not an Affiliated Entity (an "Unaffiliated Entity"), provided, however, that such request for service has been approved in writing in accordance with Code Reports and Permission (CODE RAP) or a successor process or by the Corporate Governance and Nominating Committee of the Board of Directors of the Company.
(f)    "Proceeding" shall mean any civil, criminal, administrative or investigative action, suit, proceeding or procedure in which the Indemnitee is involved in any manner including, without limitation, as a party or a witness by reason of the fact of the Indemnitee’s Position or Positions.
(g)    “Undertaking” shall mean an undertaking by Indemnitee to repay Expenses if (1) to the extent such Expenses are not covered by payments from insurance or bonds purchased pursuant to Section 359.1(1)(2) of the FDIC Regulations, the advanced Expenses subsequently are determined to be, by a court of competent jurisdiction from which no appeal can be taken, “prohibited indemnification payments”, as defined under the FDIC Regulations, or (2) it shall ultimately be determined by a court of competent jurisdiction from which no appeal can be taken that Indemnitee is not entitled to be indemnified by the Company.
(h)    “Voting Securities” means any securities of the Company that vote generally in the election of directors.
Section 2. Indemnification – General. The Company shall indemnify, subject to the terms of this Agreement, Indemnitee against all judgments, awards, fines, ERISA excise taxes, penalties, amounts paid in settlement, liabilities and losses and shall pay or reimburse all Expenses incurred by Indemnitee, subject to the terms of this Agreement, to the fullest extent permitted by Delaware law in effect on the date hereof or as amended to increase the scope of permitted indemnification, if Indemnitee is involved in any manner (including, without limitation, as a party or a witness) in any Proceeding by reason of the fact of Indemnitee's Position or Positions, including, without limitation, any Proceeding by or in the right of the Company to procure a judgment in its favor,


-2-



but excluding any Proceeding initiated by Indemnitee other than (i) Proceedings initiated by Indemnitee which are consented to in advance in writing by the Company and (ii) counterclaims made by Indemnitee in a Proceeding which directly respond to and negate the affirmative claim made against Indemnitee in such Proceeding. In the event Indemnitee incurs Expenses or settles a Proceeding under circumstances in which the Company would have an obligation to indemnify Indemnitee for the Expenses or settlement amount, the Company may discharge its indemnification obligation by making payments on behalf of Indemnitee directly to the parties to whom such Expenses or settlement amounts are owed by Indemnitee. Notwithstanding the foregoing, the Company will also, to the fullest extent permitted by Delaware law in effect on the date hereof or as amended to increase the scope of permitted indemnification, indemnify, reimburse and pay Indemnitee for Expenses incurred in seeking to enforce, interpret or construe an indemnification, reimbursement or payment right under the Company’s or any subsidiary’s certificate of incorporation or bylaws, the Company’s Indemnification Policy, any other agreement to which Indemnitee and the Company or any of its subsidiaries are party, any vote of stockholders or directors of the Company or any of its subsidiaries, the DGCL, any other applicable law or any liability insurance policy.
Section 3. Expenses. Upon receipt by the Company of an Undertaking by Indemnitee, the Company shall pay or reimburse Expenses incurred by Indemnitee in connection with a Proceeding, any action or proceeding contemplated by the last sentence of Section 2 of this Agreement and any determination contemplated by Section 5 of this Agreement, in each case in advance of its final disposition. The Company shall not impose other conditions to advancement and shall not seek or agree to any order that would prohibit Indemnitee from enforcing such right to advancement. Such payment shall be made within thirty (30) days after the receipt by the Company of a written request from Indemnitee requesting reimbursement or payment of such Expenses. Such request shall reasonably evidence the Expenses incurred by Indemnitee. The burden of proving that the Company is not liable for reimbursement or payment of Expenses shall be on the Company.
Section 4. Limitations. The Company shall not indemnify Indemnitee (1) if such indemnification or payment would constitute a "prohibited indemnification payment" under the FDIC Regulations or any other applicable laws, rules or regulations, (2) for an accounting of profits arising from the purchase and sale by the Indemnitee of securities under Section 16(b) of the Securities Exchange Act of 1934, as amended or (3) for violations of Federal or state insider trading laws, unless, in each such case, Indemnitee has been successful on the merits, received the Company's written consent prior to incurring an Expense or, after receiving the Company’s written consent to incurring the cost of settlement, settled the Proceeding. This Section 4 shall not limit the Company’s obligation to advance Expenses to Indemnitee pursuant to Section 3 of this Agreement.
Section 5. Standard of Conduct. No claim for indemnification shall be paid by the Company unless it has been determined that Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful, which is the standard of conduct set forth in Section 145 of the DGCL (as such, the "Standard of Conduct", with such Standard of Conduct to be automatically revised to conform to any successor provision of the DGCL that is more favorable to Indemnitee) except that no indemnification shall be made with respect to any Proceeding by or in right of the Company as to which the Indemnitee shall have been adjudged to be liable to the Company, except as determined by the court or other tribunal adjudicating the Proceeding. Unless (1) a Change of Control (as defined in Section 1 of this Agreement) shall have occurred, or (2) ordered by a court or other tribunal, such determinations of whether the Standard of Conduct has been satisfied shall be made by (A) a majority vote of the directors of the Company who are not parties to the Proceeding, even though less than a quorum, or (B) by a committee of such directors designated by a majority vote of such directors, even though less than a quorum, or (C) if there are no such directors, or if such directors so direct, by independent legal counsel in a written opinion, or (D) by stockholders of the Company. If a Change of Control has occurred, such determination of whether the Standard of Conduct has been satisfied shall be made by independent legal counsel in a written opinion to the Company and Indemnitee. Such independent legal counsel shall be selected by Indemnitee and approved by the Company (which approval shall not be unreasonably withheld or delayed). The Company shall pay the fees and expenses of the independent legal counsel and indemnify the independent legal counsel against any and all expenses (including attorneys’ fees), claims, liabilities and damages arising out of or relating to its engagement and shall indemnify, reimburse and pay Indemnitee for Expenses


-3-



incurred in connection with such determination. Indemnitee shall be deemed to have met the Standard of Conduct if the determination is not made by the Company within sixty days of receipt by the General Counsel of a written request by Indemnitee for indemnity. If the Indemnitee has been determined not to have met the Standard of Conduct, Indemnitee may commence litigation in any court in the State of Delaware having subject matter jurisdiction thereof and in which venue is proper seeking an initial de novo determination by the court or challenging any such determination or any aspect thereof, including the legal or factual bases therefor, and the Company hereby consents to service of process and agrees to appear in any such proceeding. Any determination under this Section 5 otherwise shall be conclusive and binding on the Company and Indemnitee. In no event shall a determination be a prerequisite to or affect the Company’s obligation to advance Expenses to Indemnitee pursuant to Section 3 of this Agreement.
Section 6. Contribution. If the full indemnification and payment or reimbursement of Expenses provided by this Agreement may not be paid to Indemnitee because it has been finally adjudicated that such indemnification or payment or reimbursement of Expenses incurred by Indemnitee is prohibited by Delaware or other law, or if it has been determined as provided above that the Standard of Conduct has not been met, and if and to the extent that Indemnitee is not entitled to coverage under the Company’s directors and officers liability insurance policy, then in respect of any such actual or threatened Proceeding in which the Company or an Affiliated Entity is jointly liable with Indemnitee (or would be if joined in such Proceeding), as determined
(a)    if no Change of Control has occurred, by (1) a majority vote of the directors of the Company who are not parties to the Proceeding, even though less than a quorum, or (2) by a committee of such directors designated by a majority vote of such directors, even though less than a quorum, or (3) if there are no such directors, or if such directors so direct, by independent legal counsel in a written opinion, or (4) by stockholders of the Company, or
(b)    if a Change of Control has occurred, by independent legal counsel in a written opinion to the Company and Indemnitee (such independent legal counsel to be selected by Indemnitee and approved by the Company (which approval shall not be unreasonably withheld or delayed)),
the Company shall contribute to the amount of loss, liability or Expenses incurred by Indemnitee in such proportion as appropriate to reflect (i) the relative benefits received by the Company and any Affiliated Entity on the one hand and Indemnitee on the other hand from the transaction from which such Proceeding arose and (ii) the relative fault of the Company, any Affiliated Entity or Unaffiliated Entity, including other persons indemnified by the Company on the one hand, and Indemnitee on the other hand in connection with the events which resulted in such Proceeding, as well as any other relevant equitable considerations. The relative fault of the Company, any Affiliated Entity or Unaffiliated Entity, including other persons indemnified by the Company, on the one hand, and of Indemnitee on the other hand shall be determined by reference to, among other things, the parties' relative intent, knowledge, access to information and opportunity to correct or prevent the circumstances resulting in such Proceeding. The Company acknowledges that it would not be just and equitable if contribution pursuant to this Section 6 were determined by pro rata allocation or any other method of allocation which does not take into account the foregoing equitable considerations.
Section 7. Defense of Claim. If any Proceeding asserted or commenced against Indemnitee is also asserted or commenced against the Company or an Affiliated Entity, the Company or the Affiliated Entity shall be entitled, except as otherwise provided herein below, to assume the defense thereof. After notice from the Company or any Affiliated Entity to Indemnitee of its election to assume the defense of any such Proceeding, Indemnitee shall have the right to employ Indemnitee's own counsel in such Proceeding, but the Expenses of such counsel incurred after notice from the Company or any Affiliated Entity to Indemnitee of its assumption of the defense thereof shall be at the expense of Indemnitee and the Company shall not be obligated to Indemnitee under this Agreement for any Expenses subsequently incurred by Indemnitee in connection therewith other than reasonable costs of investigation and reasonable travel and lodging expenses arising out of Indemnitee's participation in the defense of such Proceeding, unless (i) otherwise notified by the Company, (ii) Indemnitee's counsel shall have reasonably concluded and so notified the Company that there is a conflict of interest between the Company or any Affiliated Entity and


-4-



Indemnitee in the conduct of defense of such Proceeding, or (iii) the Company or any Affiliated Entity shall not in fact have employed counsel to assume the defense of such Proceeding, in any of which cases the Expenses of Indemnitee in such Proceeding shall be reimbursed or paid by the Company. The Company or any Affiliated Entity shall not be entitled to assume the defense of any Proceeding brought by or on behalf of the Company by its stockholders or as to which Indemnitee's counsel shall have made the conclusion set forth in clause (ii) of the preceding sentence of this Section 7.
Section 8. Settlement. The Company will not, without the prior written consent of the Indemnitee, which may be provided or withheld in Indemnitee’s sole discretion, effect any settlement of any Proceeding against Indemnitee unless such settlement solely involves the payment of money by persons other than Indemnitee and includes an unconditional release of Indemnitee from all liability arising from or relating to any matters that are the subject of such Proceeding. The Company shall not be obligated to indemnify Indemnitee against amounts paid in settlement of a Proceeding against Indemnitee if such settlement is effected by Indemnitee without the Company’s prior written consent, which shall not be unreasonably withheld.
Section 9. Duration of Agreement. This Agreement will be considered to be in effect on the first day of the Indemnitee’s Position or Positions, even if such date occurs prior to the date of this Agreement, and will continue for so long as Indemnitee may be subject to any possible Proceeding by reason of the fact of Indemnitee's Position or Positions, whether or not Indemnitee ceases to hold such Position or Positions.
Section 10. Confidentiality. Except as permitted by applicable laws pertaining to the initiation of communications to, and cooperation with, the Securities and Exchange Commission, the Financial Industry Regulatory Authority and other governmental or regulatory bodies or officials, or as otherwise becomes public (other than in violation of this Agreement) or as communicated to Indemnitee's counsel or to Indemnitee’s or the Company’s insurer, in seeking indemnification or reimbursement or payment of Expenses hereunder, Indemnitee agrees to keep confidential any information that arises in connection with this Agreement, including but not limited to, claims for indemnification or payment or reimbursement of Expenses, amounts paid or payable under this Agreement and any communications between the Indemnitee and the Company.
Section 11. Applicability to Other Indemnification Provisions. This Agreement is entered into pursuant to Section 145(f) of the DGCL and to the fullest extent permitted by law shall be in addition to indemnification and reimbursement or payment of Expenses provided by the DGCL. To the fullest extent permitted by law, the Company shall apply this Agreement, which is substantially consistent with the Company's Indemnification Policy as in effect on the date hereof, in considering requests for indemnification or reimbursement or payment of Expenses under its Indemnification Policy, certificate of incorporation, by-laws, or any other agreement or undertaking of the Company or similar constituent documents of an Affiliated Entity that provides rights to indemnification or reimbursement or payment of Expenses ("Alternate Indemnification Provisions"). For the avoidance of doubt, should there be any differences between the Company’s Indemnification Policy and this Agreement, this Agreement will govern.
Section 12. No Duplication of Payments. The Company shall indemnify and pay or reimburse Expenses of the Indemnitee in accordance with the provisions of this Agreement, provided, however, that the Company shall not be liable under this Agreement to make any payment to Indemnitee under this Agreement to the extent that Indemnitee (i) is otherwise entitled to receive reimbursement or payment of amounts otherwise payable hereunder from an Unaffiliated Entity (including insurance maintained by an Unaffiliated Entity) as a result of lndemnitee's Position or Positions at or with respect to an Unaffiliated Entity, (ii) receives payment or reimbursement under an insurance policy maintained by the Company or by or out of a fund created by the Company and under the control of a trustee or otherwise, or (iii) receives payment from other sources provided by the Company. If lndemnitee has a right of recovery from an Unaffiliated Entity (including insurance maintained by the Unaffiliated Entity), Indemnitee shall take all actions reasonably necessary to recover payment (or insurance) from the Unaffiliated Entity before seeking payment from the Company under this Agreement, including initiating a civil, criminal, administrative or investigative action, suit, proceeding or procedure; provided, however, that to the extent recovery


-5-



of such payment requires meeting a prior deductible or other financial outlay, such payment or financial outlay shall be deemed to be an Expense hereunder.
Section 13. Insurance. To the extent the Company maintains an insurance policy or policies providing directors and officers liability insurance, Indemnitee shall be covered by such policy or policies, in accordance with and subject to its or their terms, to the maximum extent of the coverage available for any member of the Board.
Section 14. Subrogation. In the event of payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee under any insurance policy or otherwise. Indemnitee shall execute all documents reasonably required and shall do everything reasonably necessary to secure such rights, including the execution of such documents necessary to enable the Company to effectively bring suit to enforce such rights.
Section 15. Notice by Indemnitee. Indemnitee shall promptly notify the Company in writing in accordance with Section 21 of this Agreement upon the earlier of (a) becoming aware of a Proceeding where indemnity or reimbursement or payment of Expenses may be sought or (b) receiving or being served with any summons, citation, subpoena, complaint, indictment, information, inquiry or other document relating to any Proceeding which may be subject to indemnification or reimbursement or payment of Expenses covered hereunder. As a condition to indemnification or reimbursement or payment of Expenses, any demand for payment by Indemnitee hereunder shall be in writing.
Section 16. Severability. If any provision of this Agreement shall be held to be invalid, inoperative or unenforceable as applied to any particular Proceeding or in any particular jurisdiction, for any reason, such circumstances shall not have the effect of rendering the provision in question invalid, inoperative or unenforceable in any other distinguishable Proceeding or jurisdiction, or of rendering any other provision or provisions herein contained invalid, inoperative or unenforceable to any extent whatsoever. The invalidity, inoperability or unenforceability of any one or more phrases, sentences, clauses or sections contained in this Agreement shall not affect any other remaining part of this Agreement.
Section 17. Binding Effect. This Agreement shall be binding upon, and inure to the benefit of, Indemnitee and Indemnitee's heirs, personal representatives, executors and administrators and upon the Company and its successors and assigns.
Section 18. Counterparts. This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but all of which together shall constitute one and the same Agreement.
Section 19. Headings. The headings of the paragraphs of this Agreement are inserted for convenience only and shall not be deemed to constitute part of this Agreement or to affect the construction thereof.
Section 20. Modification and Waiver. No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by both of the parties hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions hereof (whether or not similar) nor shall such waiver constitute a continuing waiver.
Section 21. Notices. All notices, requests, demands and other communications hereunder shall be in writing and shall be deemed to have been duly given if (i) delivered by hand, on the date delivered, (ii) mailed by certified or registered mail, with postage prepaid, on the third business day after the date on which it is mailed or (iii) sent by guaranteed overnight courier service, with postage prepaid, on the business day after the date on which it is sent:
(a)
If to Indemnitee, to the address set forth on the signature page of this Agreement;


-6-



(b)
If to the Company, to:

The Bank of New York Mellon Corporation
225 Liberty Street
New York, NY 10286
Attention: General Counsel
with copies to:

The Bank of New York Mellon Corporation
225 Liberty Street
New York, NY 10286
Attention: Corporate Secretary
or to such other address as may have been furnished to Indemnitee by the Company or to the Company by Indemnitee, as the case may be.
Section 22. Governing Law. The parties agree that this Agreement shall be governed by, and construed and enforced in accordance with, the laws of the State of Delaware.
Section 23. Venue. Any Proceeding relating to or arising from this Agreement, including without limitation, any Proceeding regarding indemnification or reimbursement or payment of Expenses arising out of this Agreement, shall only be brought and heard in the Chancery Court in and for the State of Delaware, and may not be brought in any other judicial forum.


-7-



IN WITNESS WHEREOF, the parties hereto have executed this Agreement on the day and year first above written.
THE BANK OF NEW YORK MELLON CORPORATION

By:    _______________________
Name:    
Title:    


AGREED TO AND ACCEPTED BY:

___________________________________
Name:
Address:



-8-

4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/28/24  Bank of New York Mellon Corp.     10-K       12/31/23  186:40M
 2/27/23  Bank of New York Mellon Corp.     10-K       12/31/22  180:45M
 2/25/22  Bank of New York Mellon Corp.     10-K       12/31/21  183:46M
 2/25/21  Bank of New York Mellon Corp.     10-K       12/31/20  185:44M
Top
Filing Submission 0001390777-16-000246   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 3:01:21.2pm ET